ExodusPoint Capital Management »

Aerovate Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $44k 21k 2.08

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Deerfield Management Company
Vanguard Group
BlackRock
BlackRock
Baker Bros. Advisors
Affinity Asset Advisors
Octagon Capital Advisors
Opaleye Management
GSA Capital Partners
Ikarian Capital
Acadian Asset Management

View all funds holding Aerovate Therapeutics